Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone adjunct therapy for parapneumonic effusion in children
ACTRN12624000325505Phase 4Completed
- Sponsor
- University of Child Health Sciences
- Start
- Apr 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dexamethasone in parapneumonic effusion and pneumonia (2 arms), sponsored by University of Child Health Sciences. Primary endpoint: Time to recovery of parapneumonic pleural effusion. Started Apr 2024; status: completed.
02
Drugs
dexamethasone
03
Conditions
parapneumonic effusionpneumonia
Beyond the preview
Go deeper on ACTRN12624000325505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624000325505.